Combination of the electrocardiographic strain pattern and albuminuria for the prediction of new-onset heart failure in hypertensive patients: the LIFE study.

[1]  Lauri Toivonen,et al.  Electrocardiographic Strain Pattern and Prediction of New-Onset Congestive Heart Failure in Hypertensive Patients: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study , 2005, Circulation.

[2]  B. Brenner,et al.  Albuminuria, a Therapeutic Target for Cardiovascular Protection in Type 2 Diabetic Patients With Nephropathy , 2004, Circulation.

[3]  M. Nieminen,et al.  Electrocardiographic Strain Pattern and Prediction of Cardiovascular Morbidity and Mortality in Hypertensive Patients , 2004, Hypertension.

[4]  P. Mehler,et al.  Albuminuria as a predictor of heart failure hospitalizations in patients with type 2 diabetes. , 2004, Journal of cardiac failure.

[5]  M. Nieminen,et al.  Albuminuria and Cardiovascular Risk in Hypertensive Patients with Left Ventricular Hypertrophy: The LIFE Study , 2003, Annals of Internal Medicine.

[6]  P. Guéret,et al.  Development of congestive heart failure in type 2 diabetic patients with microalbuminuria or proteinuria: observations from the DIABHYCAR (type 2 DIABetes, Hypertension, CArdiovascular Events and Ramipril) study. , 2003, Diabetes care.

[7]  B. Howard,et al.  Quantitative assessment of electrocardiographic strain predicts increased left ventricular mass: the Strong Heart Study. , 2002, Journal of the American College of Cardiology.

[8]  D. Grobbee,et al.  Microalbuminuria modifies the mortality risk associated with electrocardiographic ST-T segment changes. , 2002, Journal of the American College of Cardiology.

[9]  M. Nieminen,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .

[10]  M. Nieminen,et al.  Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE Study , 2002, Journal of hypertension.

[11]  M. Nieminen,et al.  Noninvasive cardiology abstractRelationship of the electrocardiographic strain pattern to left ventricular structure and function in hypertensive patients: the LIFE study☆ , 2002 .

[12]  S. Yusuf,et al.  Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. , 2001, JAMA.

[13]  M. Schroll,et al.  Arterial hypertension, microalbuminuria, and risk of ischemic heart disease. , 2000, Hypertension.

[14]  M. Schroll,et al.  Urinary albumin excretion. An independent predictor of ischemic heart disease. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[15]  L. Bouter,et al.  Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[16]  G. Schillaci,et al.  Prognostic value of a new electrocardiographic method for diagnosis of left ventricular hypertrophy in essential hypertension. , 1998, Journal of the American College of Cardiology.

[17]  B. Fagerberg,et al.  Usefulness of microalbuminuria in predicting cardiovascular mortality in treated hypertensive men with and without diabetes mellitus. Risk Factor Intervention Study Group. , 1997, The American journal of cardiology.

[18]  M. Nieminen,et al.  The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group. , 1997, American journal of hypertension.

[19]  K. Borch-Johnsen,et al.  Detecting microalbuminuria by urinary albumin/creatinine concentration ratio. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[20]  J. Hoyer.  Endothelial vasoregulation and mechanosensitive ion channels in hypertension. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[21]  J. Wikstrand,et al.  Urinary albumin excretion--a predictor of risk of cardiovascular disease. A prospective 10-year follow-up of middle-aged nondiabetic normal and hypertensive men. , 1996, American journal of hypertension.

[22]  R. Vasan,et al.  The progression from hypertension to congestive heart failure. , 1996, JAMA.

[23]  P Kligfield,et al.  Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products. , 1995, Journal of the American College of Cardiology.

[24]  G. Schillaci,et al.  Improved electrocardiographic diagnosis of left ventricular hypertrophy. , 1994, The American journal of cardiology.

[25]  K. Borch-Johnsen,et al.  Microalbuminuria: an important diagnostic tool. , 1994, Journal of diabetes and its complications.

[26]  C. Mogensen,et al.  Microalbuminuria as predictor of increased mortality in elderly people. , 1990, BMJ.

[27]  C. Jackson,et al.  MICROALBUMINURIA AS PREDICTOR OF VASCULAR DISEASE IN NON-DIABETIC SUBJECTS Islington Diabetes Survey , 1988, The Lancet.

[28]  J. Kastrup,et al.  Microalbuminuria: an early marker of renal involvement in diabetes. , 1985, Uremia investigation.

[29]  R. Deitch.  Commentary from Westminster , 1984, The Lancet.

[30]  W. Kannel.  Prevalence and natural history of electrocardiographic left ventricular hypertrophy. , 1983, The American journal of medicine.

[31]  N. Reichek,et al.  Repolarization abnormalities of left ventricular hypertrophy. Clinical, echocardiographic and hemodynamic correlates. , 1982, Journal of electrocardiology.

[32]  M. Sokolow,et al.  The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. , 1949, American heart journal.